A detailed history of Maven Securities LTD transactions in Natera, Inc. stock. As of the latest transaction made, Maven Securities LTD holds 2,000 shares of NTRA stock, worth $262,220. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$262,220
Previous $216,000 -0.0%
% of portfolio
0.04%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$85.28 - $112.6 $170,560 - $225,200
2,000 New
2,000 $216,000
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $1.85 Million - $2.33 Million
-18,461 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$86.05 - $119.72 $144,047 - $200,411
-1,674 Reduced 8.31%
18,461 $2.11 Million
Q1 2021

May 17, 2021

SELL
$91.47 - $124.36 $694,897 - $944,762
-7,597 Reduced 27.39%
20,135 $2.01 Million
Q4 2020

Feb 12, 2021

BUY
$66.66 - $111.74 $1.85 Million - $3.1 Million
27,732 New
27,732 $2.76 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.